NATURE’S SUNSHINE PRODUCTS, INC. Inventory, Work in Process, Net of Reserves
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Inventory, Work in Process, Net of Reserves of $1.39 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Work in Process, Net of Reserves $1.39M.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $1.24M.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $1.25M.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $1.28M.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.24M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.25M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.44M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.21M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.01M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.15M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.59M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.22M 10-K · filed 2025-03-11 |
| 2023-09-30 | $1.47M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.50M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.61M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.71M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.88M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.93M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.82M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.75M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.62M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.74M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.78M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.35M 10-K · filed 2022-03-08 |
| 2020-09-30 | $1.49M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.29M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.27M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.43M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.80M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.29M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.24M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.52M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.94M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.96M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.17M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.15M 10-K · filed 2019-03-08 |
| 2017-09-30 | $758.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.14M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $158.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $694.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | $1.16M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.04M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $758.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $789.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $946.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $928.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $743.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $534.00K 10-K · filed 2016-03-14 |
| 2014-09-30 | $957.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $800.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $759.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $740.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $931.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $954.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $775.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $742.00K 10-K · filed 2014-03-17 |
| 2012-09-30 | $931.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $1.53M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $1.23M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |